Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Tennessee for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Tennessee only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Tennessee (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Richard Breazeale (NPI 1801892146)

Field	Value
Entity Type	Individual
Organization	Richard Breazeale
Address	1605 Williams Rd
City	Hixson
State	TN
ZIP	37343
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 22, 2005

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider has reported lifetime Medicare revenue of $2.1M and has no Medicaid billing on file, making their Medicare business effectively single‑payer in scale; there is no Medicaid revenue to evaluate for payer diversification or state-level Medicaid market positioning. The absence of Medicaid activity means analysis of in‑state Medicaid competitive standing is not applicable for this profile.

Revenue is highly concentrated in three drug/injection codes: the precomputed top‑3 Medicare codes account for 83.2% of this provider's total Medicare revenue, with J2778 alone representing $1.1M (52.4% of Medicare revenue), J0178 $462.2K (21.8%), and J2777 $191.4K (9.0%). This concentration indicates that a large majority of Medicare dollars come from intravitreal pharmaceutical treatments rather than broad clinic-based E/M or ancillary testing.

Service-line profile is consistent with a retina-focused, procedure-centric practice: high volumes of intravitreal drug injections (J2778, J0178, J2777) are complemented by the intravitreal injection procedure 67028 (1.5K claims, $143.6K, 6.8% of revenue) and retinal imaging 92134 (2.1K claims, $57.7K, 2.7% of revenue). These CPT/HCPCS codes imply the operation is organized around repeat, procedure-driven encounters (drug administration and retinal imaging) rather than primarily longitudinal office visits.

Competitive standing is uneven across codes: for the dominant drug J2778 the provider ranks #30 of 1208 nationally (98th percentile) and is described as "notably above typical national volume for this code," signaling a nationally prominent role in billing for ranibizumab. By contrast, J0178 (rank #1676 of 3204, 48th percentile) and J2777 (rank #1325 of 2039, 35th percentile) are in typical or modest national volume ranges, indicating the provider’s prominence is focused specifically on J2778.

Ancillary and diagnostic codes show selective strengths: 92134 is also "notably above typical national volume for this code" (rank #978 of 26868, 96th percentile), supporting significant retinal imaging throughput, while 67028 ranks #752 of 4255 (82th percentile) and contributes meaningfully to revenue. Together, these patterns highlight a workflow that pairs high-volume drug administration with diagnostic imaging capacity.

Evaluation-and-management (E/M) billing is a relatively small part of the revenue mix: 92014 generated $41.3K (2.0%), 99213 $26.5K (1.3%), and 99214 $11.2K (0.5%) of Medicare revenue, with these E/M codes ranked in mid-to-high percentiles but accounting for only a minor fraction of total dollars. This suggests the practice is procedure-dominant—regular injection visits and tests drive patient encounters more than billable, higher-revenue E/M time.

There are few statistical outliers beyond the J2778 and 92134 callouts: several drug and imaging codes are described as "typical, unremarkable volume for this code" (for example J0178, J2777, J3490), and some low-volume imaging codes (e.g., 92235, 76512) sit at lower national percentiles, indicating the provider’s high-volume concentration is specific rather than broad-based across retinal services. This pattern points to focused clinical activity rather than uniformly high utilization across all retina-related codes.

The provider’s NPI was enumerated 2005-06-22 (~21 years ago), indicating a long-tenured practice; combined with the concentrated revenue in high-volume intravitreal drug and imaging codes, this tenure supports the interpretation of an established retina specialist whose Medicare business is built around repeat injection treatments and diagnostic imaging workflows.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2778	Injection, ranibizumab, 0.1 mg	6,120	$180	$1.1M
J0178	Injection, aflibercept, 1 mg	670	$690	$462.2K
J2777	Injection, faricimab‑svoa, 0.1 mg	6,600	$30	$191.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,540	$90	$143.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,060	$30	$57.7K
J3490	Unclassified drugs	30	$1,720	$48.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	500	$80	$41.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	430	$60	$26.5K
J9035	Injection, bevacizumab, 10 mg	250	$60	$13.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	130	$90	$11.2K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Tennessee Distribution

Richard Breazeale — 0 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Tennessee

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	43	80	790	$680	$769.8K
J2777	39	50	15,060	$30	$592.1K
J2778	3	40	1,340	$180	$370.2K
67028	30	80	1,130	$90	$98.5K
J3490	51	60	70	$400	$41.9K
92014	123	810	120	$80	$19.2K
J9035	26	70	140	$50	$17.1K
99214	5,395	11,370	120	$80	$16.6K
92134	32	600	60	$30	$8.2K
99213	785	11,030	80	$50	$8K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with Richard Breazeale, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
James Miller	TN	Retina Specialist (Ophthalmology) Physician	$3.9M	$0
Devon Ghodasra	TN	Retina Specialist (Ophthalmology) Physician	$3.6M	$0
Nicholas Anderson	TN	Retina Specialist (Ophthalmology) Physician	$3M	$0
Rohan Shah	TN	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Scott Barb	TN	Ophthalmology Physician	$2.8M	$0
Robert Shuler	TN	Retina Specialist (Ophthalmology) Physician	$2.6M	$0
Tod Mcmillan	TN	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Ailee Laham	TN	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Stephen Perkins	TN	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Francis Decroos	TN	Retina Specialist (Ophthalmology) Physician	$2.3M	$0

Nearby Providers

Other providers in the same ZIP code as Richard Breazeale, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Galen Medical Group, PC	TN	Internal Medicine Physician	$0	$10.2M
Agilitas Usa Inc	TN	Physical Therapy Clinic/Center	$0	$7.4M
Dental Center, Inc	TN	Dentist	$0	$7.4M
Lighthouse Kids Hixson, LLC	TN	Behavior Analyst	$0	$3.7M
Hixson Pediatric Dentistry PLLC	TN	Pediatric Dentistry	$0	$3.2M
Memorial Health Care System Inc.	TN	General Acute Care Hospital	$0	$2.4M
Chattanooga Pain Management Center LLC	TN	Ambulatory Surgical Clinic/Center	$2.4M	$1.6K
Chelsea Schwind	TN	Dentist	$0	$2.2M
Summit Physical Therapy, LLC	TN	Physical Therapy Clinic/Center	$0	$2.1M
Joseph Huffstutter	TN	Rheumatology Physician	$1.9M	$0

Richard Breazeale — Billing Profile & Reimbursement Data

Sign up for Richard Breazeale — Billing Profile & Reimbursement Data policy alerts

Richard Breazeale — Billing Profile & Reimbursement Data

Sign up for Richard Breazeale — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References